BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yerxa B. Progress in Inherited Retinal Disease Drug Discovery and Development: A Foundation's Perspective. Pharm Res 2018;35:239. [PMID: 30338398 DOI: 10.1007/s11095-018-2514-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Junnuthula V, Sadeghi Boroujeni A, Cao S, Tavakoli S, Ridolfo R, Toropainen E, Ruponen M, van Hest JCM, Urtti A. Intravitreal Polymeric Nanocarriers with Long Ocular Retention and Targeted Delivery to the Retina and Optic Nerve Head Region. Pharmaceutics 2021;13:445. [PMID: 33810242 DOI: 10.3390/pharmaceutics13040445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Koulisis N, Nagiel A. Precision Therapy for Inherited Retinal Disease. Clinics in Laboratory Medicine 2020;40:189-204. [DOI: 10.1016/j.cll.2020.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 O'Hare F, Edwards TL, Hu ML, Hickey DG, Zhang AC, Wang JH, Liu Z, Ayton LN. An optometrist's guide to the top candidate inherited retinal diseases for gene therapy. Clin Exp Optom 2021;104:431-43. [PMID: 33689629 DOI: 10.1080/08164622.2021.1878851] [Reference Citation Analysis]